ArticleBlood advances2024

The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and synergizes with MCL-1 inhibition in B-cell precursor ALL.

Maren Christiane Wichert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.